Apos® Demonstrates 43% Reduction in Healthcare Utilization and Costs for Patients with Knee and Back Pain

Claims data has shown a 43% reduction in healthcare utilisation and costs for patients with knee and back pain treated with Apos®. The findings offer a view of what happens across the wider healthcare journey, not only during a single treatment visit.

People in the Apos® group used fewer diagnostic and outpatient services and had lower use of non-operative treatments. The data also showed reduced use of pain medication, including opioids, as well as fewer injections. These changes matter because chronic pain often brings a long series of appointments and interventions that can be tiring for patients as well as costly for health providers.

The importance of this kind of analysis is its breadth. Instead of focusing on one isolated outcome, claims data follows patterns of care over time: the tests people receive, the treatments they try and the medication they use. A reduction across those areas suggests a wider shift in how ongoing pain may be supported.

The claims analysis also found very low rates of subsequent knee surgery among patients treated with Apos®. Taken together, the results point towards a care pathway that can support people earlier and reduce reliance on more invasive or medication-based options.

For patients, that can mean fewer steps in the healthcare journey and more support directed towards the movement they want to recover. For providers, it offers useful evidence about how a non-invasive intervention can influence both care decisions and the resources needed over time.

Apos® is a non-invasive, drug-free device designed to be worn during everyday movement. By making support part of a person’s normal routine, it offers a practical direction for people managing ongoing knee or back pain and for health services looking for sustainable ways to reduce demand while keeping patients moving.